USD 1.77
(-0.28%)
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2023 | 6.99 Million USD | -41.59% |
2022 | 11.96 Million USD | 168.26% |
2021 | -17.53 Million USD | 32.13% |
2020 | -25.83 Million USD | -44.61% |
2019 | -17.86 Million CAD | -315.93% |
2018 | 8.27 Million CAD | 552.15% |
2017 | 1.26 Million CAD | 223.56% |
2016 | -1.02 Million CAD | -608.15% |
2015 | -144.98 Thousand CAD | -350.76% |
2014 | -32.16 Thousand CAD | 83.56% |
2013 | -195.61 Thousand CAD | 0.0% |
Year | Gross Profit | Gross Profit Growth |
---|---|---|
2024 Q2 | 5.27 Million USD | 57.85% |
2024 Q1 | 3.34 Million USD | 135.19% |
2023 Q4 | 1.42 Million USD | -64.18% |
2023 Q2 | 3.09 Million USD | 30.21% |
2023 Q3 | 3.97 Million USD | 28.11% |
2023 Q1 | 2.38 Million USD | 1117.09% |
2023 FY | 6.99 Million USD | -41.59% |
2022 Q4 | -234 Thousand USD | -120.22% |
2022 Q3 | 1.15 Million USD | -71.92% |
2022 Q2 | 4.12 Million USD | -40.51% |
2022 FY | 11.96 Million USD | 168.26% |
2022 Q1 | 6.92 Million USD | 256.46% |
2021 Q3 | -730 Thousand USD | 95.38% |
2021 Q4 | 1.94 Million USD | 366.16% |
2021 Q1 | -2.96 Million USD | 80.11% |
2021 FY | -17.53 Million USD | 32.13% |
2021 Q2 | -15.78 Million USD | -432.7% |
2020 Q1 | -6.47 Million USD | 68.22% |
2020 Q3 | -1.53 Million USD | 47.95% |
2020 Q4 | -14.89 Million USD | -869.29% |
2020 FY | -25.83 Million USD | -44.61% |
2020 Q2 | -2.95 Million USD | 54.4% |
2019 Q4 | -20.37 Million CAD | -39.29% |
2019 Q3 | -14.62 Million CAD | -423.18% |
2019 Q2 | 4.52 Million CAD | 55.57% |
2019 Q1 | 2.9 Million CAD | 1071.99% |
2019 FY | -17.86 Million CAD | -315.93% |
2018 Q2 | -371.4 Thousand CAD | -124.88% |
2018 Q1 | 1.49 Million CAD | 831.02% |
2018 Q3 | 1.62 Million CAD | 536.38% |
2018 FY | 8.27 Million CAD | 552.15% |
2018 Q4 | 248.24 Thousand CAD | -84.68% |
2017 Q2 | 16.94 Thousand CAD | 112.39% |
2017 FY | 1.26 Million CAD | 223.56% |
2017 Q4 | -204.22 Thousand CAD | -155.3% |
2017 Q3 | 369.31 Thousand CAD | 2080.01% |
2017 Q1 | -136.75 Thousand CAD | 86.92% |
2016 Q1 | -37.91 Thousand CAD | 13.98% |
2016 Q3 | -39.45 Thousand CAD | -116.45% |
2016 Q2 | -18.22 Thousand CAD | 51.93% |
2016 Q4 | -1.04 Million CAD | -2548.99% |
2016 FY | -1.02 Million CAD | -608.15% |
2015 Q2 | -37.83 Thousand CAD | 1.54% |
2015 Q4 | -44.08 Thousand CAD | -48.78% |
2015 FY | -144.98 Thousand CAD | -350.76% |
2015 Q3 | -29.62 Thousand CAD | 21.69% |
2015 Q1 | -38.42 Thousand CAD | 0.0% |
2014 Q3 | - CAD | 0.0% |
2014 Q2 | - CAD | 0.0% |
2014 FY | -32.16 Thousand CAD | 83.56% |
2013 Q2 | - CAD | 0.0% |
2013 Q3 | - CAD | 0.0% |
2013 FY | -195.61 Thousand CAD | 0.0% |
Name | Gross Profit | Gross Profit Difference |
---|---|---|
Collegium Pharmaceutical, Inc. | 326.16 Million USD | 97.857% |
China SXT Pharmaceuticals, Inc. | 553.97 Thousand USD | -1161.961% |
Embecta Corp. | 749.9 Million USD | 99.068% |
Pacira BioSciences, Inc. | 490.3 Million USD | 98.574% |
PainReform Ltd. | -15 Thousand USD | 46705.973% |
Sunshine Biopharma, Inc. | 8.33 Million USD | 16.168% |
SCYNEXIS, Inc. | 124.51 Million USD | 94.386% |
Journey Medical Corporation | 52.52 Million USD | 86.689% |
Safety Shot Inc | -74.45 Thousand USD | 9489.172% |
Alpha Teknova, Inc. | 10.29 Million USD | 32.101% |
Bright Green Corporation | -237.01 Thousand USD | 3049.546% |
Procaps Group, S.A. | 239.56 Million USD | 97.082% |
Alvotech | -69.42 Million USD | 110.07% |
ANI Pharmaceuticals, Inc. | 305.3 Million USD | 97.71% |
Aquestive Therapeutics, Inc. | 29.75 Million USD | 76.503% |
Cosmos Health Inc. | 4.34 Million USD | -60.726% |
Dynavax Technologies Corporation | 182.11 Million USD | 96.161% |
Esperion Therapeutics, Inc. | 73.06 Million USD | 90.432% |
Intra-Cellular Therapies, Inc. | 430.62 Million USD | 98.377% |
Sunshine Biopharma, Inc. | 8.33 Million USD | 16.168% |
Theratechnologies Inc. | 62.12 Million USD | 88.748% |
Harrow Health, Inc. | 90.55 Million USD | 92.28% |
Sonoma Pharmaceuticals, Inc. | 4.74 Million USD | -47.332% |
Biofrontera Inc. | 16.62 Million USD | 57.955% |
DURECT Corporation | 6.83 Million USD | -2.341% |
Supernus Pharmaceuticals, Inc. | 523.74 Million USD | 98.665% |
OptiNose, Inc. | 62.35 Million USD | 88.788% |
Ironwood Pharmaceuticals, Inc. | 441.16 Million USD | 98.415% |
Kala Pharmaceuticals, Inc. | -303 Thousand USD | 2407.226% |
RedHill Biopharma Ltd. | 3.05 Million USD | -128.897% |
Organogenesis Holdings Inc. | 309.79 Million USD | 97.743% |
Guardion Health Sciences, Inc. | 5.39 Million USD | -29.593% |
Cumberland Pharmaceuticals Inc. | 33.48 Million USD | 79.123% |
Radius Health, Inc. | 307.71 Million USD | 97.728% |
Universe Pharmaceuticals INC | 10.07 Million USD | 30.631% |
ProPhase Labs, Inc. | 16.23 Million USD | 56.95% |
Phibro Animal Health Corporation | 312.48 Million USD | 97.763% |
Procaps Group S.A. | 239.56 Million USD | 97.082% |
TherapeuticsMD, Inc. | 1.3 Million USD | -436.935% |
Viatris Inc. | 6.43 Billion USD | 99.891% |
Rockwell Medical, Inc. | 8.7 Million USD | 19.682% |
Aytu BioPharma, Inc. | 54.58 Million USD | 87.193% |
SIGA Technologies, Inc. | 122.09 Million USD | 94.274% |
Tilray Brands, Inc. | 223.35 Million USD | 96.87% |
Lifecore Biomedical, Inc. | 41.85 Million USD | 83.295% |
Shineco, Inc. | 882.16 Thousand USD | -692.468% |
PetIQ, Inc. | 252.74 Million USD | 97.234% |
Regencell Bioscience Holdings Limited | -745.58 Thousand USD | 1037.635% |
Incannex Healthcare Limited | 12 Thousand USD | -58157.467% |
Neurocrine Biosciences, Inc. | 1.84 Billion USD | 99.622% |
Alimera Sciences, Inc. | 61.17 Million USD | 88.571% |
Silver Spike Investment Corp. | 8.1 Million USD | 13.72% |
Assertio Holdings, Inc. | 125.04 Million USD | 94.409% |
Shuttle Pharmaceuticals Holdings, Inc. | -6811.00 USD | 102741.257% |
Petros Pharmaceuticals, Inc. | 4.19 Million USD | -66.801% |
Clever Leaves Holdings Inc. | 6.55 Million USD | -6.634% |
Cyclo Therapeutics, Inc. | -2.41 Million USD | 390.057% |
Avadel Pharmaceuticals plc | 27.11 Million USD | 74.22% |
Hempacco Co., Inc. | -1.21 Million USD | 674.988% |
Talphera, Inc. | -4.89 Million USD | 242.817% |
Alvotech | -69.42 Million USD | 110.07% |
Eagle Pharmaceuticals, Inc. | 221.67 Million USD | 96.846% |
Lantheus Holdings, Inc. | 709.54 Million USD | 99.015% |
Currenc Group, Inc. | 17.35 Million USD | 59.721% |
Kamada Ltd. | 52.59 Million USD | 86.707% |
Indivior PLC | 907 Million USD | 99.229% |
Evoke Pharma, Inc. | 4.97 Million USD | -40.415% |
Flora Growth Corp. | 17.73 Million USD | 60.588% |
Cyclo Therapeutics, Inc. | -2.41 Million USD | 390.057% |
Evolus, Inc. | 140.52 Million USD | 95.025% |
HUTCHMED (China) Limited | 453.55 Million USD | 98.459% |
Amphastar Pharmaceuticals, Inc. | 343.96 Million USD | 97.968% |
Akanda Corp. | 111.44 Thousand USD | -6172.731% |